Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
Go back to Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 3.96 +0.11 (2.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.85 | 52 Week High | $ | |||
| Open | $3.91 | 52 Week Low | $ | |||
| Day High | $4.07 | P/E | N/A | |||
| Day Low | $3.85 | EPS | $ | |||
| Volume | 1,132,036 | |||||

